IMPORTANT: please refer to detailed limits of scope and interfaces with Lot 1 (platform) in Annex 1 onto https://pha2.edf.com/ Procurement Notices ref AVIS018997. Lot 2 is the Supply of 30MW PEM Electrolyzer module, BoS and optimized for operation on a platform at sea comprising: - Supply - Integration - Testing - Pre -commissioning plan - Commissioning plan Reminder :This Market Notice follows a previous Notice referenced 2023/S 181-565305, which allowed qualification on Lots 1 and 3 (with Lot 2 still to be qualified). The contracting authority reserves the right to terminate the Partnership Contracts in accordance with the provisions set forth therein and in accordance with Article R. 2172-31 of the Public Procurement Code. Phasing of Lot 2 : - T0 = Launch of Market notice (“Avis de marché”) - T0 + 2 months = Submission of application by candidates - T0 + 3 months: Qualification of maximum 2 candidates (=T1) - T1 + 2 months: signature with EDF Renouvelables (to become EDF power solutions) of 1 or 2 innovation partnership agreements to perform pre-FEED studies with Lot 1 and/or Lot 3 partners (=T2) - T2 + 6 months = selection of one unique Lot 2 partner as Subcontractor fo Lot 1 to move forward until COD - Continuation as electrolyzer subcontractor of Lot 1 partner (plafform) during project operations The partnership agreement related to Lot 2 will consist for the qualified candidate(s) of performing engineering studies (pre-FEED) in close interaction with the Lot 1 (platform) partner to develop a specific offshore electrolysis unit design in accordance with HYODE project specifications.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start Free| Issuing agency | EDF Renouvelables |
|---|
| Country | France |
|---|
| Category | Pharmaceuticals |
|---|
| CPV | 24111600 |
|---|
| Published | September 16, 2025 |
|---|
| Procurement stage | Request for Proposal (RFP) |
|---|
| Response due | Not specified / rolling |
|---|
| Status | Open — accepting responses |
|---|
| Official source | View original notice |
|---|
| Last verified | October 10, 2026 |
|---|
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
See every France Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free France Pharmaceuticals intelligence report in your inbox
A personalized report on France Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.